Sally Bennett
Fortune : 3 981 $ au 30/09/2026
Fortune : 3 981 $ au 30/09/2026
Sally Bennett is currently Director at Mosaic Therapeutics Ltd. and P4 Precision Medicine Accelerator.
The current roles also include Independent Member-Supervisory Board at Innate Pharma SA since 2022, Member at The Institute of Directors, and Member-Governors Council at University College London Hospitals NHS Foundation Trust.
Former roles include Independent Non-Executive Director at Oncoinvent ASA, Analyst at ING Bank NV (United Kingdom), Senior Member at HealthCor Management LP, Senior Research Analyst at Piper Sandler Ltd. from 2006 to 2007, and Analyst at Healthcor Management UK LLP from 2008 to 2014.
Education includes undergraduate and doctorate degrees from The University of Manchester.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/03/2026 | 2 500 ( 0 % ) | 3 981 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INNATE PHARMA | Directeur/Membre du Conseil | 20/05/2022 |
The Institute of Directors
The Institute of Directors Miscellaneous Commercial ServicesCommercial Services Provides informative events and professional development courses | Corporate Officer/Principal | - |
University College London Hospitals NHS Foundation Trust
University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services Operates hospitals | Corporate Officer/Principal | - |
P4 Precision Medicine Accelerator
P4 Precision Medicine Accelerator Miscellaneous Commercial ServicesCommercial Services Develops health organization program | Directeur/Membre du Conseil | - |
Mosaic Therapeutics Ltd.
Mosaic Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel targeted therapies using computational methods and next-generation cancer models | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Healthcor Management UK LLP
Healthcor Management UK LLP Investment ManagersFinance Alternative investment manager | Analyst-Equity | 02/07/2014 |
Piper Sandler Ltd.
Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 30/04/2007 |
HealthCor Management LP
HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Corporate Officer/Principal | - |
| ONCOINVENT ASA | Directeur/Membre du Conseil | - |
| ░░░ ░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
ING Bank NV (United Kingdom)
ING Bank NV (United Kingdom) Investment Banks/BrokersFinance Provides brokerage services | Finance |
HealthCor Management LP
HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Finance |
Piper Sandler Ltd.
Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
The Institute of Directors
The Institute of Directors Miscellaneous Commercial ServicesCommercial Services Provides informative events and professional development courses | Commercial Services |
Healthcor Management UK LLP
Healthcor Management UK LLP Investment ManagersFinance Alternative investment manager | Finance |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
University College London Hospitals NHS Foundation Trust
University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
P4 Precision Medicine Accelerator
P4 Precision Medicine Accelerator Miscellaneous Commercial ServicesCommercial Services Develops health organization program | Commercial Services |
Mosaic Therapeutics Ltd.
Mosaic Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel targeted therapies using computational methods and next-generation cancer models | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national